RecruitingNot ApplicableNCT05429827

The Therapeutic Effects of Dextrose Injection for Myofascial Pain Syndrome


Sponsor

National Cheng-Kung University Hospital

Enrollment

30 participants

Start Date

Nov 18, 2022

Study Type

INTERVENTIONAL

Conditions

Summary

Patients with an myofascial trigger point (MTrP) in their upper trapezius will be divided into three groups: Group A receiving MTrP injection with normal saline (control group), Group B with hypo-osmolar dextrose (5% dextrose), and Group C with hyper-osmolar dextrose (15% dextrose). Clinical outcomes and morphological changes will be measured before the injection, one hour after, one week after, two weeks after, and one month after the injection to delineate the therapeutic effects of dextrose injection for an MTrP.


Eligibility

Min Age: 20 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Dextrose 15% in water, a drug called Dextrose 5% in water, and others for people with myofascial trigger point pain. The study is currently recruiting participants at 1 location. People eligible for this study include aged 20 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERnormal saline

Inject 2 ml normal saline into a myofascial trigger point and evaluate the clinical effects before and after the injection.

DRUGDextrose 5% in water

Inject 2 ml 5% dextrose into a myofascial trigger point and evaluate the clinical effects before and after the injection.

DRUGDextrose 15% in water

Inject 2 ml 15% dextrose into a myofascial trigger point and evaluate the clinical effects before and after the injection.


Locations(1)

Department of physical Medicine and Rehabilitation, National Cheng Kung University Hospital

Tainan, Taiwan

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05429827


Related Trials